山河药辅：预计2025年度归母净利润同比增长38.16%-62.45%

Core Viewpoint - The company, Shanhe Pharmaceutical, announced an expected net profit attributable to shareholders of 165 million to 194 million yuan for the fiscal year 2025, representing a year-on-year growth of 38.16% to 62.45% [1] Financial Performance - The projected net profit range for 2025 is between 165 million yuan and 194 million yuan [1] - This forecast indicates a significant increase in profitability compared to the previous year, with growth rates between 38.16% and 62.45% [1]